{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:53:53Z","timestamp":1792083233269,"version":"4.4.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health\/NIAID","doi-asserted-by":"crossref","award":["R01AI137075"],"award-info":[{"award-number":["R01AI137075"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Veteran Affairs Merit Award","award":["1I01CX002212"],"award-info":[{"award-number":["1I01CX002212"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Human Leukocyte Antigen (HLA) class-II genes, particularly HLA-DR2 and HLA-DR3, and the gut microbiota are intricately linked to the pathobiology of multiple sclerosis (MS) through their ability to regulate host immunity, a critical factor in disease pathogenesis. An imbalance between anti-inflammatory CD4\n                      <jats:sup>+<\/jats:sup>\n                      Tregs and pro-inflammatory IL-17A-secreting CD4\n                      <jats:sup>+<\/jats:sup>\n                      Th17 cells is thought to drive disease. However, a key unresolved question is whether HLA-class II-restricted CD4\n                      <jats:sup>+<\/jats:sup>\n                      IL-17A cells can influence Treg populations and the extent to which gut microbiota regulate this IL-17A-Treg axis. Therefore, we utilized humanized transgenic mice expressing the HLA class-II gene and deficient in mouse class-II molecules, where all CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells are selected on the human HLA class-II molecule, closely mimicking human immune responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Utilizing IL-17A-deficient (DR3.IL-17A\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ) mice expressing HLA-DR3 (HLA-DR\u03b21*0301), we show that IL-17A deficiency enriches beneficial gut bacteria, including\n                      <jats:italic>Prevotella species<\/jats:italic>\n                      , enhances peroxisome proliferator\u2013activated receptor (PPAR) signaling, and increases FoxP3\n                      <jats:sup>+<\/jats:sup>\n                      regulatory T (Treg) cells and IL-10 production. The importance of gut microbiota in promoting Tregs and anti-inflammatory responses was confirmed by administering\n                      <jats:italic>Prevotella copri<\/jats:italic>\n                      , a common commensal in human gut, which mirrored the effects observed in IL-17A-deficient mice by inducing PPAR signaling and Treg population. Moreover, DR3.IL-17A\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice exhibited a marked reduction in EAE severity compared to IL-17A-sufficient (DR3) mice, underscoring the enhanced functional capacity of the Treg population in mitigating disease progression. Cohousing experiments validated the role of gut microbiota in immune regulation including Treg induction, as demonstrated by the transfer of\n                      <jats:italic>Prevotella species<\/jats:italic>\n                      from IL-17A-deficient mice to IL-17A-sufficient mice, increased Treg populations and attenuated EAE severity in recipient DR3 mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study redefines IL-17A's role in immune regulation, emphasizing its ability to directly influence gut microbiota composition and the abundance of Treg-promoting bacteria. Thus, gut microbiota-targeted therapies, particularly those promoting Treg-inducing bacteria like\n                      <jats:italic>Prevotella species<\/jats:italic>\n                      , hold promise for treating autoimmune diseases by modulating host immune responses.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-026-02394-w","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:35:23Z","timestamp":1782750923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IL-17A deficiency in HLA-DR3 transgenic mice enriches beneficial Prevotella species in gut to promote Tregs and reduce CNS autoimmunity"],"prefix":"10.1186","volume":"14","author":[{"given":"Shailesh K.","family":"Shahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha N.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Rux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souradip","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Borcherding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir R.","family":"Tanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N.","family":"Gibson-Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukirth M.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin J.","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9926-2531","authenticated-orcid":false,"given":"Ashutosh K.","family":"Mangalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2394_CR1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1212\/WNL.55.12.1897","volume":"55","author":"C de la Alvarado- Barrera","year":"2000","unstructured":"de la Alvarado- Barrera C, et al. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology. 2000;55:1897\u2013900.","journal-title":"Neurology"},{"key":"2394_CR2","doi-asserted-by":"publisher","first-page":"20896","DOI":"10.1073\/pnas.0707731105","volume":"104","author":"GC DeLuca","year":"2007","unstructured":"DeLuca GC, et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A. 2007;104:20896\u2013901.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2394_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/hmg\/ddi206","volume":"14","author":"DA Dyment","year":"2005","unstructured":"Dyment DA, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005;14:2019\u201326. https:\/\/doi.org\/10.1093\/hmg\/ddi206.","journal-title":"Hum Mol Genet"},{"key":"2394_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.1991.tb02029.x","volume":"38","author":"O Olerup","year":"1991","unstructured":"Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991;38:1\u201315.","journal-title":"Tissue Antigens"},{"key":"2394_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00415-008-0878-7","volume":"255","author":"SV Ramagopalan","year":"2008","unstructured":"Ramagopalan SV, et al. Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. J Neurol. 2008;255:1215\u20139.","journal-title":"J Neurol"},{"key":"2394_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","volume":"126","author":"MM Curtis","year":"2009","unstructured":"Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 2009;126:177\u201385. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03017.x.","journal-title":"Immunology"},{"key":"2394_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485\u2013517. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132710.","journal-title":"Annu Rev Immunol"},{"key":"2394_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","volume":"11","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic J, et al. Interleukin-17 in chronic inflammatory neurological diseases. Front Immunol. 2020;11:947. https:\/\/doi.org\/10.3389\/fimmu.2020.00947.","journal-title":"Front Immunol"},{"key":"2394_CR9","doi-asserted-by":"publisher","unstructured":"Chong WP, et al. The Cytokine IL-17A Limits Th17 Pathogenicity via a negative feedback loop driven by autocrine induction of IL-24. Immunity. 2020;53:384\u2013397 e385. https:\/\/doi.org\/10.1016\/j.immuni.2020.06.022","DOI":"10.1016\/j.immuni.2020.06.022"},{"key":"2394_CR10","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.4049\/jimmunol.1801042","volume":"201","author":"PS Biswas","year":"2018","unstructured":"Biswas PS. IL-17 in renal immunity and autoimmunity. J Immunol. 2018;201:3153\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1801042.","journal-title":"J Immunol"},{"key":"2394_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","volume":"226","author":"Y Iwakura","year":"2008","unstructured":"Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev. 2008;226:57\u201379. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00699.x.","journal-title":"Immunol Rev"},{"key":"2394_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019;50:892\u2013906. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.021.","journal-title":"Immunity"},{"key":"2394_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1089\/jir.2014.0025","volume":"34","author":"BM Segal","year":"2014","unstructured":"Segal BM. Stage-specific immune dysregulation in multiple sclerosis. J Interferon Cytokine Res. 2014;34:633\u201340. https:\/\/doi.org\/10.1089\/jir.2014.0025.","journal-title":"J Interferon Cytokine Res"},{"key":"2394_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nri2660","volume":"9","author":"CT Weaver","year":"2009","unstructured":"Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009;9:883\u20139. https:\/\/doi.org\/10.1038\/nri2660.","journal-title":"Nat Rev Immunol"},{"key":"2394_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","volume":"4","author":"II Ivanov","year":"2008","unstructured":"Ivanov II, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337\u201349. https:\/\/doi.org\/10.1016\/j.chom.2008.09.009.","journal-title":"Cell Host Microbe"},{"key":"2394_CR16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1136\/gut.2004.059451","volume":"54","author":"UG Strauch","year":"2005","unstructured":"Strauch UG, et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut. 2005;54:1546\u201352. https:\/\/doi.org\/10.1136\/gut.2004.059451.","journal-title":"Gut"},{"key":"2394_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nature13279","volume":"510","author":"Y Yang","year":"2014","unstructured":"Yang Y, et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature. 2014;510:152\u20136. https:\/\/doi.org\/10.1038\/nature13279.","journal-title":"Nature"},{"key":"2394_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500:232\u20136. https:\/\/doi.org\/10.1038\/nature12331.","journal-title":"Nature"},{"key":"2394_CR19","doi-asserted-by":"publisher","unstructured":"Regen T, et al. IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci Immunol. 2021;6. https:\/\/doi.org\/10.1126\/sciimmunol.aaz6563","DOI":"10.1126\/sciimmunol.aaz6563"},{"key":"2394_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fonc.2014.00280","volume":"4","author":"N Kaushansky","year":"2014","unstructured":"Kaushansky N, Ben-Nun A. DQB1*06:02-associated pathogenic anti-myelin autoimmunity in multiple sclerosis-like disease: potential function of DQB1*06:02 as a disease-predisposing allele. Front Oncol. 2014;4:280. https:\/\/doi.org\/10.3389\/fonc.2014.00280.","journal-title":"Front Oncol"},{"key":"2394_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clim.2003.12.012","volume":"111","author":"J Klehmet","year":"2004","unstructured":"Klehmet J, et al. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis. Clin Immunol. 2004;111:53\u201360. https:\/\/doi.org\/10.1016\/j.clim.2003.12.012.","journal-title":"Clin Immunol"},{"key":"2394_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2011.05.001","volume":"37","author":"D Luckey","year":"2011","unstructured":"Luckey D, Bastakoty D, Mangalam AK. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice. J Autoimmun. 2011;37:122\u20138. https:\/\/doi.org\/10.1016\/j.jaut.2011.05.001.","journal-title":"J Autoimmun"},{"key":"2394_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cellimm.2018.05.003","volume":"331","author":"SA Nalawade","year":"2018","unstructured":"Nalawade SA, et al. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4. Cell Immunol. 2018;331:38\u201348. https:\/\/doi.org\/10.1016\/j.cellimm.2018.05.003.","journal-title":"Cell Immunol"},{"key":"2394_CR24","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.4049\/jimmunol.1103087","volume":"189","author":"JA Quandt","year":"2012","unstructured":"Quandt JA, et al. Myelin basic protein-specific TCR\/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis. J Immunol. 2012;189:2897\u2013908. https:\/\/doi.org\/10.4049\/jimmunol.1103087.","journal-title":"J Immunol"},{"key":"2394_CR25","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.4049\/jimmunol.0803918","volume":"182","author":"A Mangalam","year":"2009","unstructured":"Mangalam A, et al. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice. J Immunol. 2009;182:5131\u20139.","journal-title":"J Immunol"},{"key":"2394_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/eji.200324597","volume":"34","author":"AK Mangalam","year":"2004","unstructured":"Mangalam AK, Khare M, Krco C, Rodriguez M, David C. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur J Immunol. 2004;34:280\u201390. https:\/\/doi.org\/10.1002\/eji.200324597.","journal-title":"Eur J Immunol"},{"key":"2394_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2004.12.012","volume":"161","author":"AK Mangalam","year":"2005","unstructured":"Mangalam AK, Khare M, Krco CJ, Rodriguez M, David CS. Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide(91-110) and critical residues required for induction of EAE in HLA-DR3 transgenic mice. J Neuroimmunol. 2005;161:40\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.12.012.","journal-title":"J Neuroimmunol"},{"key":"2394_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jaut.2012.02.004","volume":"38","author":"AK Mangalam","year":"2012","unstructured":"Mangalam AK, et al. Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. J Autoimmun. 2012;38:344\u201353. https:\/\/doi.org\/10.1016\/j.jaut.2012.02.004.","journal-title":"J Autoimmun"},{"key":"2394_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0065-2776(08)00002-3","volume":"97","author":"AK Mangalam","year":"2008","unstructured":"Mangalam AK, Rajagopalan G, Taneja V, David CS. HLA class II transgenic mice mimic human inflammatory diseases. Adv Immunol. 2008;97:65\u2013147. https:\/\/doi.org\/10.1016\/S0065-2776(08)00002-3.","journal-title":"Adv Immunol"},{"key":"2394_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","volume":"44","author":"P Kumar","year":"2016","unstructured":"Kumar P, et al. Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity. 2016;44:659\u201371. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.007.","journal-title":"Immunity"},{"key":"2394_CR31","doi-asserted-by":"publisher","first-page":"115428","DOI":"10.1016\/j.biopha.2023.115428","volume":"166","author":"N Oliveras-Canellas","year":"2023","unstructured":"Oliveras-Canellas N, et al. Inflammatory response to bacterial lipopolysaccharide drives iron accumulation in human adipocytes. Biomed Pharmacother. 2023;166:115428. https:\/\/doi.org\/10.1016\/j.biopha.2023.115428.","journal-title":"Biomed Pharmacother"},{"key":"2394_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12964-022-00849-9","volume":"20","author":"Y Miao","year":"2022","unstructured":"Miao Y, et al. The activation of PPARgamma enhances Treg responses through up-regulating CD36\/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TbetaRII\/IL-2Ralpha. Cell Commun Signal. 2022;20:48. https:\/\/doi.org\/10.1186\/s12964-022-00849-9.","journal-title":"Cell Commun Signal"},{"key":"2394_CR33","doi-asserted-by":"publisher","first-page":"750078","DOI":"10.3389\/fphar.2021.750078","volume":"12","author":"Z Gao","year":"2021","unstructured":"Gao Z, et al. Mechanistic insight into PPARgamma and Tregs in atherosclerotic immune inflammation. Front Pharmacol. 2021;12:750078. https:\/\/doi.org\/10.3389\/fphar.2021.750078.","journal-title":"Front Pharmacol"},{"key":"2394_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.63.6.12","volume":"63","author":"X Guo","year":"2022","unstructured":"Guo X, et al. PPAR-alpha Agonist Fenofibrate Ameliorates Sjogren Syndrome-Like Dacryoadenitis by Modulating Th1\/Th17 and Treg Cell Responses in NOD Mice. Invest Ophthalmol Vis Sci. 2022;63:12. https:\/\/doi.org\/10.1167\/iovs.63.6.12.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2394_CR35","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nri912","volume":"2","author":"RA Daynes","year":"2002","unstructured":"Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2:748\u201359. https:\/\/doi.org\/10.1038\/nri912.","journal-title":"Nat Rev Immunol"},{"key":"2394_CR36","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1084\/jem.20082771","volume":"206","author":"L Klotz","year":"2009","unstructured":"Klotz L, et al. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med. 2009;206:2079\u201389. https:\/\/doi.org\/10.1084\/jem.20082771.","journal-title":"J Exp Med"},{"key":"2394_CR37","doi-asserted-by":"publisher","unstructured":"Tett A, et al. The Prevotella copri complex comprises four distinct clades underrepresented in westernized populations. Cell Host Microbe. 2019;26:666\u2013679 e667. https:\/\/doi.org\/10.1016\/j.chom.2019.08.018","DOI":"10.1016\/j.chom.2019.08.018"},{"key":"2394_CR38","doi-asserted-by":"publisher","first-page":"e2413953122","DOI":"10.1073\/pnas.2413953122","volume":"122","author":"S Ghimire","year":"2025","unstructured":"Ghimire S, et al. Specific microbial ratio in the gut microbiome is associated with multiple sclerosis. Proc Natl Acad Sci U S A. 2025;122:e2413953122. https:\/\/doi.org\/10.1073\/pnas.2413953122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2394_CR39","doi-asserted-by":"publisher","first-page":"578648","DOI":"10.3389\/fimmu.2020.578648","volume":"11","author":"SK Shahi","year":"2020","unstructured":"Shahi SK, et al. Human commensal Prevotella histicola ameliorates disease as effectively as interferon-beta in the experimental autoimmune encephalomyelitis. Front Immunol. 2020;11:578648. https:\/\/doi.org\/10.3389\/fimmu.2020.578648.","journal-title":"Front Immunol"},{"key":"2394_CR40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/cmi.2015.10","volume":"12","author":"Z Li","year":"2015","unstructured":"Li Z, Li D, Tsun A, Li B. FOXP3+ regulatory T cells and their functional regulation. Cell Mol Immunol. 2015;12:558\u201365. https:\/\/doi.org\/10.1038\/cmi.2015.10.","journal-title":"Cell Mol Immunol"},{"key":"2394_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057\u201361. https:\/\/doi.org\/10.1126\/science.1079490.","journal-title":"Science"},{"key":"2394_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/cei.12466","volume":"179","author":"AD Christensen","year":"2015","unstructured":"Christensen AD, Skov S, Kvist PH, Haase C. Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells. Clin Exp Immunol. 2015;179:485\u201399. https:\/\/doi.org\/10.1111\/cei.12466.","journal-title":"Clin Exp Immunol"},{"key":"2394_CR43","doi-asserted-by":"publisher","unstructured":"Jensen SN, et al. Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis. Sci Adv. 2021;7. https:\/\/doi.org\/10.1126\/sciadv.abd4595","DOI":"10.1126\/sciadv.abd4595"},{"key":"2394_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","volume":"177","author":"Y Komiyama","year":"2006","unstructured":"Komiyama Y, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006;177:566\u201373. https:\/\/doi.org\/10.4049\/jimmunol.177.1.566.","journal-title":"J Immunol"},{"key":"2394_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.immuni.2008.12.010","volume":"30","author":"PJ Dubin","year":"2009","unstructured":"Dubin PJ, Kolls JK. Interleukin-17A and interleukin-17F: a tale of two cytokines. Immunity. 2009;30:9\u201311. https:\/\/doi.org\/10.1016\/j.immuni.2008.12.010.","journal-title":"Immunity"},{"key":"2394_CR46","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4049\/jimmunol.1701484","volume":"200","author":"PC Duncker","year":"2018","unstructured":"Duncker PC, Stoolman JS, Huber AK, Segal BM. GM-CSF promotes chronic disability in experimental autoimmune encephalomyelitis by altering the composition of central nervous system-infiltrating cells, but is dispensable for disease induction. J Immunol. 2018;200:966\u201373. https:\/\/doi.org\/10.4049\/jimmunol.1701484.","journal-title":"J Immunol"},{"key":"2394_CR47","doi-asserted-by":"publisher","first-page":"e1700492","DOI":"10.1126\/sciadv.1700492","volume":"3","author":"I Cosorich","year":"2017","unstructured":"Cosorich I, et al. High frequency of intestinal T(H)17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv. 2017;3:e1700492. https:\/\/doi.org\/10.1126\/sciadv.1700492.","journal-title":"Sci Adv"},{"key":"2394_CR48","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1074\/jbc.RA118.003541","volume":"293","author":"JH Sohn","year":"2018","unstructured":"Sohn JH, et al. Perilipin 1 (Plin1) deficiency promotes inflammatory responses in lean adipose tissue through lipid dysregulation. J Biol Chem. 2018;293:13974\u201388. https:\/\/doi.org\/10.1074\/jbc.RA118.003541.","journal-title":"J Biol Chem"},{"key":"2394_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.chom.2011.12.006","volume":"11","author":"X Wei","year":"2012","unstructured":"Wei X, et al. Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. Cell Host Microbe. 2012;11:140\u201352. https:\/\/doi.org\/10.1016\/j.chom.2011.12.006.","journal-title":"Cell Host Microbe"},{"key":"2394_CR50","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","volume":"63","author":"P Gissen","year":"2015","unstructured":"Gissen P, Arias IM. Structural and functional hepatocyte polarity and liver disease. J Hepatol. 2015;63:1023\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2015.06.015.","journal-title":"J Hepatol"},{"key":"2394_CR51","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1039\/d3ob02081a","volume":"22","author":"S Gao","year":"2024","unstructured":"Gao S, et al. (NH(4))(2)S(2)O(8) promoted tandem radical cyclization of quinazolin-4(3H)-ones with oxamic acids for the construction of fused quinazolinones under metal-free conditions. Org Biomol Chem. 2024;22:2241\u201351. https:\/\/doi.org\/10.1039\/d3ob02081a.","journal-title":"Org Biomol Chem"},{"key":"2394_CR52","doi-asserted-by":"publisher","first-page":"104540","DOI":"10.1016\/j.nedt.2020.104540","volume":"93","author":"M Caboral-Stevens","year":"2020","unstructured":"Caboral-Stevens M, Ignacio RV, Newberry G. Undergraduate nursing students\u2019 pharmacology knowledge and risk of error estimate. Nurse Educ Today. 2020;93:104540. https:\/\/doi.org\/10.1016\/j.nedt.2020.104540.","journal-title":"Nurse Educ Today"},{"key":"2394_CR53","doi-asserted-by":"publisher","unstructured":"Lin Q, Ane C, Givnish TJ, Graham SW. A new carnivorous plant lineage (Triantha) with a unique sticky-inflorescence trap. Proc Natl Acad Sci U S A. 2021;118. https:\/\/doi.org\/10.1073\/pnas.2022724118","DOI":"10.1073\/pnas.2022724118"},{"key":"2394_CR54","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s00330-013-2953-4","volume":"23","author":"A Harloff","year":"2013","unstructured":"Harloff A, et al. Wall shear stress distribution at the carotid bifurcation: influence of eversion carotid endarterectomy. Eur Radiol. 2013;23:3361\u20139. https:\/\/doi.org\/10.1007\/s00330-013-2953-4.","journal-title":"Eur Radiol"},{"key":"2394_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"D Cipolletta","year":"2012","unstructured":"Cipolletta D, et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 2012;486:549\u201353. https:\/\/doi.org\/10.1038\/nature11132.","journal-title":"Nature"},{"key":"2394_CR56","doi-asserted-by":"publisher","first-page":"e105763","DOI":"10.1371\/journal.pone.0105763","volume":"9","author":"VP Kashi","year":"2014","unstructured":"Kashi VP, Ortega SB, Karandikar NJ. Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function. PLoS ONE. 2014;9:e105763. https:\/\/doi.org\/10.1371\/journal.pone.0105763.","journal-title":"PLoS ONE"},{"key":"2394_CR57","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3389\/fimmu.2017.01429","volume":"8","author":"MMM Kaisar","year":"2017","unstructured":"Kaisar MMM, Pelgrom LR, van der Ham AJ, Yazdanbakhsh M, Everts B. Butyrate conditions human dendritic cells to prime type 1 regulatory T cells via both histone deacetylase inhibition and G protein-coupled receptor 109A signaling. Front Immunol. 2017;8:1429. https:\/\/doi.org\/10.3389\/fimmu.2017.01429.","journal-title":"Front Immunol"},{"key":"2394_CR58","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1037\/tra0000651","volume":"12","author":"YJ Shin","year":"2020","unstructured":"Shin YJ, Lee JY. South Korea\u2019s proactive approach to the COVID-19 global crisis. Psychol Trauma. 2020;12:475\u20137. https:\/\/doi.org\/10.1037\/tra0000651.","journal-title":"Psychol Trauma"},{"key":"2394_CR59","doi-asserted-by":"publisher","unstructured":"Kopanska M, Lagowska A, Kuduk B, Banas-Zabczyk A, Acrylamide neurotoxicity as a possible factor responsible for inflammation in the cholinergic nervous system. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23042030","DOI":"10.3390\/ijms23042030"},{"key":"2394_CR60","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fimmu.2019.00462","volume":"10","author":"SK Shahi","year":"2019","unstructured":"Shahi SK, et al. Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE\u00ae in an Animal Model of Multiple Sclerosis. Front Immunol. 2019;10:462. https:\/\/doi.org\/10.3389\/fimmu.2019.00462.","journal-title":"Front Immunol"},{"key":"2394_CR61","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.celrep.2017.07.031","volume":"20","author":"A Mangalam","year":"2017","unstructured":"Mangalam A, et al. Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Rep. 2017;20:1269\u201377. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.031.","journal-title":"Cell Rep"},{"key":"2394_CR62","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1189\/jlb.3A0815-359R","volume":"100","author":"D Ghosh","year":"2016","unstructured":"Ghosh D, Curtis AD, Wilkinson DS, Mannie MD. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-\/- mice. J Leukoc Biol. 2016;100:747\u201360. https:\/\/doi.org\/10.1189\/jlb.3A0815-359R.","journal-title":"J Leukoc Biol"},{"key":"2394_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1172\/JCI35997","volume":"119","author":"S Haak","year":"2009","unstructured":"Haak S, et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest. 2009;119:61\u20139. https:\/\/doi.org\/10.1172\/JCI35997.","journal-title":"J Clin Invest"},{"key":"2394_CR64","doi-asserted-by":"publisher","first-page":"e92362","DOI":"10.1172\/jci.insight.92362","volume":"2","author":"ER Pierson","year":"2017","unstructured":"Pierson ER, Goverman JM. GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease. JCI Insight. 2017;2:e92362. https:\/\/doi.org\/10.1172\/jci.insight.92362.","journal-title":"JCI Insight"},{"key":"2394_CR65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00109-018-1662-5","volume":"96","author":"F Wanke","year":"2018","unstructured":"Wanke F, et al. Expression of IL-17F is associated with non-pathogenic Th17 cells. J Mol Med (Berl). 2018;96:819\u201329. https:\/\/doi.org\/10.1007\/s00109-018-1662-5.","journal-title":"J Mol Med (Berl)"},{"key":"2394_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40259-020-00462-7","volume":"35","author":"K Chwojnicki","year":"2021","unstructured":"Chwojnicki K, et al. Administration of CD4(+)CD25(high)CD127(-)FoxP3(+) regulatory T cells for relapsing-remitting multiple sclerosis: a phase 1 study. BioDrugs. 2021;35:47\u201360. https:\/\/doi.org\/10.1007\/s40259-020-00462-7.","journal-title":"BioDrugs"},{"key":"2394_CR67","doi-asserted-by":"publisher","first-page":"19194","DOI":"10.1038\/s41598-019-55713-7","volume":"9","author":"SK Shahi","year":"2019","unstructured":"Shahi SK, Freedman SN, Dahl RA, Karandikar NJ, Mangalam AK. Scoring disease in an animal model of multiple sclerosis using a novel infrared-based automated activity-monitoring system. Sci Rep. 2019;9:19194. https:\/\/doi.org\/10.1038\/s41598-019-55713-7.","journal-title":"Sci Rep"},{"key":"2394_CR68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0198-8859(99)00135-4","volume":"61","author":"P Das","year":"2000","unstructured":"Das P, et al. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum Immunol. 2000;61:279\u201389.","journal-title":"Hum Immunol"},{"key":"2394_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139. https:\/\/doi.org\/10.1038\/nmeth.1923.","journal-title":"Nat Methods"},{"key":"2394_CR70","doi-asserted-by":"publisher","first-page":"11257","DOI":"10.1038\/ncomms11257","volume":"7","author":"P Menzel","year":"2016","unstructured":"Menzel P, Ng KL, Krogh A. Fast and sensitive taxonomic classification for metagenomics with Kaiju. Nat Commun. 2016;7:11257. https:\/\/doi.org\/10.1038\/ncomms11257.","journal-title":"Nat Commun"},{"key":"2394_CR71","doi-asserted-by":"publisher","first-page":"D529","DOI":"10.1093\/nar\/gkw989","volume":"45","author":"DR Mende","year":"2017","unstructured":"Mende DR, et al. ProGenomes: a resource for consistent functional and taxonomic annotations of prokaryotic genomes. Nucleic Acids Res. 2017;45:D529\u201334. https:\/\/doi.org\/10.1093\/nar\/gkw989.","journal-title":"Nucleic Acids Res"},{"key":"2394_CR72","unstructured":"R Core Team. R. A language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria. 2020."},{"key":"2394_CR73","doi-asserted-by":"publisher","unstructured":"Beghini F, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10. https:\/\/doi.org\/10.7554\/eLife.65088","DOI":"10.7554\/eLife.65088"},{"key":"2394_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34:525\u20137. https:\/\/doi.org\/10.1038\/nbt.3519.","journal-title":"Nat Biotechnol"},{"key":"2394_CR75","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. EdgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics"},{"key":"2394_CR76","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36:2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"key":"2394_CR77","doi-asserted-by":"publisher","first-page":"e66772","DOI":"10.1371\/journal.pone.0066772","volume":"8","author":"AF Tyler","year":"2013","unstructured":"Tyler AF, Mendoza JP, Firan M, Karandikar NJ. CD8(+) T cells are required for glatiramer acetate therapy in autoimmune demyelinating disease. PLoS ONE. 2013;8:e66772. https:\/\/doi.org\/10.1371\/journal.pone.0066772.","journal-title":"PLoS ONE"},{"key":"2394_CR78","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.4049\/jimmunol.1302008","volume":"193","author":"AK Mangalam","year":"2014","unstructured":"Mangalam AK, et al. <article-title update=\"added\">Absence of IFN-\u03b3 increases brain pathology in experimental autoimmune encephalomyelitis\u2013susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes\/microglia into the central nervous system. J Immunol. 2014;193:4859\u201370. https:\/\/doi.org\/10.4049\/jimmunol.1302008.","journal-title":"J Immunol"},{"key":"2394_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaut.2017.09.008","volume":"86","author":"L Goschl","year":"2018","unstructured":"Goschl L, et al. A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis. J Autoimmun. 2018;86:51\u201361. https:\/\/doi.org\/10.1016\/j.jaut.2017.09.008.","journal-title":"J Autoimmun"},{"key":"2394_CR80","doi-asserted-by":"publisher","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura VK, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214. https:\/\/doi.org\/10.1126\/science.1241214.","journal-title":"Science"},{"key":"2394_CR81","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287\u201396. https:\/\/doi.org\/10.1084\/jem.188.2.287.","journal-title":"J Exp Med"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-026-02394-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:55:47Z","timestamp":1782960947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40168-026-02394-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2394"],"URL":"https:\/\/doi.org\/10.1186\/s40168-026-02394-w","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Institutional Animal Care and Use Committee at the University of Iowa.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AKM is the inventor of a technology claiming the use of Prevotella histicola for the treatment of autoimmune diseases. The patent for the technology is owned by the Mayo Clinic, which has given an exclusive license to Evelo Biosciences. AKM received royalties from Mayo Clinic (paid by Evelo Biosciences). However, no funds or products from the patent were used in the present study. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}